Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Phakic Intraocular Lenses Market: By Product, Posterior Chamber Intraocular Lenses ), By Indication, By End Users and Region Forecast 2020-2031
Phakic Intraocular Lenses Market size was valued at US$ 386.3 million in 2023 and is poised to grow at a CAGR of 5% from 2025-2031. Phakic intraocular lenses are synthetic lenses made of plastic or silicone, that are implanted over natural lenses inside eyes to rectify the ametropic condition. Phakic lenses are utilized to correct refractive errors, errors in the eye's focusing power. It has advantages over laser therapy such as a wide range of corrections, reversibility, fewer complications, outperforming other therapies in terms of best spectacle-corrected visual acuity (BSCVA), and preservation of natural lens.
An increasing number of myopic patients, rise in the prevalence of diabetes, grow in the number old age people with developing eye disorders, increasing screen time from the usage of gadgets, advancements in healthcare in developed countries, and increasing acceptance of the therapy are the main driving forces of the market. The phakic intraocular lens remains a main trend among the young generation in developed countries who prefer permanent lenses instead of wearing specs. Countries such as China, India, Japan, and South Korea prevail in the number of myopes consisting up to 80% of the population being myopic which is a main opportunity for the key players in the market as research is being done continuously to reduce the cost of implantation, thus successfully entering the developing countries. The biggest restraint for this market to expand is the cost of the implantation, the lack of reimbursement policies for the patients undergoing surgery, and the advancements in alternative options such as glasses, lenses, LASIK therapy, and photorefractive keratectomy.
Study Period
2025-2031Base Year
2024CAGR
5%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Major brands are launching new and improved products for the treatment of ametropic conditions. The increasing demand and preference from the youth generation, adaptation from old generation and reduction of the cost of implantation will help to expand the market. The increasing prevalence of diabetes is also a main driving factor of ametropic conditions which in turn a tapping opportunity for implantation. The expected growth of myopes is around 50% of the world population by 2050. Moreover, development and launch of newer products by the companies significantly enhances the revenue of phakic intraocular lens market over the forecast timeframe.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2023 |
US$ 386.3 million |
Market CAGR |
5% |
By Product |
|
By Coundition |
|
By End User |
|
By Region |
|
Download Free Sample Report
Phakic Intraocular Lenses Market size was valued at US$ 386.3 million in 2023 and is poised to grow at a CAGR of 5% from 2025-2031.
North America dominates the Phakic Intraocular Lenses Market with the largest revenue share
The biggest restraint for this market to expand is the cost of the implantation, lack of reimbursement policies for the patient’s undergoing surgery and the advancements in alternative options such as glasses, lenses, LASIK therapy, and photorefractive keratectomy.
1. Executive Summary |
2. Global Phakic Intraocular Lenses Market Introduction |
2.1. Global Phakic Intraocular Lenses Market - Taxonomy |
2.2. Global Phakic Intraocular Lenses Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Indication |
2.2.3. By End User |
2.2.4. By Region |
3. Global Phakic Intraocular Lenses Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Phakic Intraocular Lenses Market By Product Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
4.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
4.1.1. Angle-supported ACIOLs |
4.1.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.1.3. Market Opportunity Analysis |
4.1.2. Iris-claw ACIOLs |
4.1.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.2.3. Market Opportunity Analysis |
4.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
4.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3. Market Opportunity Analysis |
5. Global Phakic Intraocular Lenses Market By Indication, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
5.1. Myopia |
5 1 1 Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Hyperopia |
5.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Astigmatism |
5.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Phakic Intraocular Lenses Market By End User, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ophthalmology Clinics |
6.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Ambulatory Surgical Centers |
6.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Phakic Intraocular Lenses Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Phakic Intraocular Lenses Market - Opportunity Analysis Index, By Indication, Product Type, End User, and Region, 2024-2030 |
8. North America Phakic Intraocular Lenses Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
8.1. Product Type Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
8.1.1.1. Angle-supported ACIOLs |
8.1.1.2. Iris-claw ACIOLs |
8.1.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
8.2. Indication Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Myopia |
8.2.2. Hyperopia |
8.2.3. Astigmatism |
8.3. End User Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Hospitals |
8.3.2. Ophthalmology Clinics |
8.3.3. Ambulatory Surgical Centers |
8.4. Country Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Phakic Intraocular Lenses Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
9.1. Product Type Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
9.1.1.1. Angle-supported ACIOLs |
9.1.1.2. Iris-claw ACIOLs |
9.1.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
9.2. Indication Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Myopia |
9.2.2. Hyperopia |
9.2.3. Astigmatism |
9.3. End User Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Ophthalmology Clinics |
9.3.3. Ambulatory Surgical Centers |
9.4. Country Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. France |
9.4.3. Italy |
9.4.4. Spain |
9.4.5. UK |
9.4.6. Rest of Europe |
10. Asia Pacific Phakic Intraocular Lenses Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
10.1. Product Type Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
10.1.1.1. Angle-supported ACIOLs |
10.1.1.2. Iris-claw ACIOLs |
10.1.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
10.2. Indication Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Myopia |
10.2.2. Hyperopia |
10.2.3. Astigmatism |
10.3. End User Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Ophthalmology Clinics |
10.3.3. Ambulatory Surgical Centers |
10.4. Country Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. Japan |
10.4.3. South Korea |
10.4.4. India |
10.4.5. Rest of APAC |
11. Latin America Phakic Intraocular Lenses Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
11.1. Product Type Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
11.1.1.1. Angle-supported ACIOLs |
11.1.1.2. Iris-claw ACIOLs |
11.1.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
11.2. Indication Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Myopia |
11.2.2. Hyperopia |
11.2.3. Astigmatism |
11.3. End User Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Ophthalmology Clinics |
11.3.3. Ambulatory Surgical Centers |
11.4. Country Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Phakic Intraocular Lenses Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
12.1. Product Type Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Anterior Chamber Intraocular Lenses (ACIOLs) |
12.1.1.1. Angle-supported ACIOLs |
12.1.1.2. Iris-claw ACIOLs |
12.1.2. Posterior Chamber Intraocular Lenses (PCIOLs) |
12.2. Indication Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Myopia |
12.2.2. Hyperopia |
12.2.3. Astigmatism |
12.3. End User Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Ophthalmology Clinics |
12.3.3. Ambulatory Surgical Centers |
12.4. Country Analysis, 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Johnson and Johnson |
13.2.2. Carl Zeiss Meditec |
13.2.3. Ophtec BV |
13.2.4. Care Group |
13.2.5. Alcon Laboratories |
13.2.6. STAAR Surgical |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players